aluates Reports

$ 0.0

Automative

Global Gynecological Cancer Diagnostics Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-30P10282

Global Gynecological Cancer Diagnostics Market Research Report 2022

BUY CHAPTERS

Global Gynecological Cancer Diagnostics Market Research Report 2025

Code: QYRE-Auto-30P10282

Report

February 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abramson Cancer Center

Fujirebio

Agilent Technologies Inc

ARUP Laboratories

CENTOGENE

F Hoffmann La Roche Ltd

Fulgent Genetics Inc

Invitae Corporation

Myriad Genetics Inc

BGI Group

UT Southwestern

Northwestern Medicine

Sysmex Europe SE

Premier Health

Gynecological Cancer Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gynecological Cancer Diagnostics Market

The global market for Gynecological Cancer Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gynecological Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecological Cancer Diagnostics.

The Gynecological Cancer Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gynecological Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gynecological Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gynecological Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Gynecological Cancer Diagnostics Market
CAGR	5%
Segment by Type	Genetic Counseling Test Cancer Risk Test Kits Test
Segment by Application	Gestational Trophoblastic Disease Diagnostics Endometrial Cancer Diagnostics Peritoneal Cancer Diagnostics Cervical Cancer Diagnostics Ovarian Cancer Diagnostics Vaginal Cancer Diagnostics Uterine Cancer Diagnostics Vulvar Cancer Diagnostics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories, CENTOGENE, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc, Invitae Corporation, Myriad Genetics, Inc, BGI Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gynecological Cancer Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gynecological Cancer Diagnostics Market report?

Ans: The main players in the Gynecological Cancer Diagnostics Market are UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories, CENTOGENE, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc, Invitae Corporation, Myriad Genetics, Inc, BGI Group

What are the Application segmentation covered in the Gynecological Cancer Diagnostics Market report?

Ans: The Applications covered in the Gynecological Cancer Diagnostics Market report are Gestational Trophoblastic Disease Diagnostics, Endometrial Cancer Diagnostics, Peritoneal Cancer Diagnostics, Cervical Cancer Diagnostics, Ovarian Cancer Diagnostics, Vaginal Cancer Diagnostics, Uterine Cancer Diagnostics, Vulvar Cancer Diagnostics

What are the Type segmentation covered in the Gynecological Cancer Diagnostics Market report?

Ans: The Types covered in the Gynecological Cancer Diagnostics Market report are Genetic Counseling Test, Cancer Risk Test, Kits Test

Recommended Reports

Cancer Diagnostics

Gynecological Markets

Clinical Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genetic Counseling Test

1.2.3 Cancer Risk Test

1.2.4 Kits Test

1.3 Market by Application

1.3.1 Global Gynecological Cancer Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gestational Trophoblastic Disease Diagnostics

1.3.3 Endometrial Cancer Diagnostics

1.3.4 Peritoneal Cancer Diagnostics

1.3.5 Cervical Cancer Diagnostics

1.3.6 Ovarian Cancer Diagnostics

1.3.7 Vaginal Cancer Diagnostics

1.3.8 Uterine Cancer Diagnostics

1.3.9 Vulvar Cancer Diagnostics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gynecological Cancer Diagnostics Market Perspective (2020-2031)

2.2 Global Gynecological Cancer Diagnostics Growth Trends by Region

2.2.1 Global Gynecological Cancer Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gynecological Cancer Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Gynecological Cancer Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Gynecological Cancer Diagnostics Market Dynamics

2.3.1 Gynecological Cancer Diagnostics Industry Trends

2.3.2 Gynecological Cancer Diagnostics Market Drivers

2.3.3 Gynecological Cancer Diagnostics Market Challenges

2.3.4 Gynecological Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gynecological Cancer Diagnostics Players by Revenue

3.1.1 Global Top Gynecological Cancer Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Gynecological Cancer Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Gynecological Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gynecological Cancer Diagnostics Revenue

3.4 Global Gynecological Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Gynecological Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gynecological Cancer Diagnostics Revenue in 2024

3.5 Global Key Players of Gynecological Cancer Diagnostics Head office and Area Served

3.6 Global Key Players of Gynecological Cancer Diagnostics, Product and Application

3.7 Global Key Players of Gynecological Cancer Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gynecological Cancer Diagnostics Breakdown Data by Type

4.1 Global Gynecological Cancer Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2026-2031)

5 Gynecological Cancer Diagnostics Breakdown Data by Application

5.1 Global Gynecological Cancer Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gynecological Cancer Diagnostics Market Size (2020-2031)

6.2 North America Gynecological Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gynecological Cancer Diagnostics Market Size by Country (2020-2025)

6.4 North America Gynecological Cancer Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gynecological Cancer Diagnostics Market Size (2020-2031)

7.2 Europe Gynecological Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gynecological Cancer Diagnostics Market Size by Country (2020-2025)

7.4 Europe Gynecological Cancer Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Gynecological Cancer Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gynecological Cancer Diagnostics Market Size (2020-2031)

9.2 Latin America Gynecological Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gynecological Cancer Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Gynecological Cancer Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Gynecological Cancer Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 UT Southwestern

11.1.1 UT Southwestern Company Details

11.1.2 UT Southwestern Business Overview

11.1.3 UT Southwestern Gynecological Cancer Diagnostics Introduction

11.1.4 UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.1.5 UT Southwestern Recent Development

11.2 Abramson Cancer Center

11.2.1 Abramson Cancer Center Company Details

11.2.2 Abramson Cancer Center Business Overview

11.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Introduction

11.2.4 Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.2.5 Abramson Cancer Center Recent Development

11.3 Northwestern Medicine

11.3.1 Northwestern Medicine Company Details

11.3.2 Northwestern Medicine Business Overview

11.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Introduction

11.3.4 Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.3.5 Northwestern Medicine Recent Development

11.4 Sysmex Europe SE

11.4.1 Sysmex Europe SE Company Details

11.4.2 Sysmex Europe SE Business Overview

11.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Introduction

11.4.4 Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.4.5 Sysmex Europe SE Recent Development

11.5 Fujirebio

11.5.1 Fujirebio Company Details

11.5.2 Fujirebio Business Overview

11.5.3 Fujirebio Gynecological Cancer Diagnostics Introduction

11.5.4 Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.5.5 Fujirebio Recent Development

11.6 Premier Health

11.6.1 Premier Health Company Details

11.6.2 Premier Health Business Overview

11.6.3 Premier Health Gynecological Cancer Diagnostics Introduction

11.6.4 Premier Health Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.6.5 Premier Health Recent Development

11.7 Agilent Technologies, Inc

11.7.1 Agilent Technologies, Inc Company Details

11.7.2 Agilent Technologies, Inc Business Overview

11.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Introduction

11.7.4 Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.7.5 Agilent Technologies, Inc Recent Development

11.8 ARUP Laboratories

11.8.1 ARUP Laboratories Company Details

11.8.2 ARUP Laboratories Business Overview

11.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Introduction

11.8.4 ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.8.5 ARUP Laboratories Recent Development

11.9 CENTOGENE

11.9.1 CENTOGENE Company Details

11.9.2 CENTOGENE Business Overview

11.9.3 CENTOGENE Gynecological Cancer Diagnostics Introduction

11.9.4 CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.9.5 CENTOGENE Recent Development

11.10 F. Hoffmann-La Roche Ltd

11.10.1 F. Hoffmann-La Roche Ltd Company Details

11.10.2 F. Hoffmann-La Roche Ltd Business Overview

11.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Introduction

11.10.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.10.5 F. Hoffmann-La Roche Ltd Recent Development

11.11 Fulgent Genetics, Inc

11.11.1 Fulgent Genetics, Inc Company Details

11.11.2 Fulgent Genetics, Inc Business Overview

11.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Introduction

11.11.4 Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.11.5 Fulgent Genetics, Inc Recent Development

11.12 Invitae Corporation

11.12.1 Invitae Corporation Company Details

11.12.2 Invitae Corporation Business Overview

11.12.3 Invitae Corporation Gynecological Cancer Diagnostics Introduction

11.12.4 Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.12.5 Invitae Corporation Recent Development

11.13 Myriad Genetics, Inc

11.13.1 Myriad Genetics, Inc Company Details

11.13.2 Myriad Genetics, Inc Business Overview

11.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Introduction

11.13.4 Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.13.5 Myriad Genetics, Inc Recent Development

11.14 BGI Group

11.14.1 BGI Group Company Details

11.14.2 BGI Group Business Overview

11.14.3 BGI Group Gynecological Cancer Diagnostics Introduction

11.14.4 BGI Group Revenue in Gynecological Cancer Diagnostics Business (2020-2025)

11.14.5 BGI Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abramson Cancer Center

Fujirebio

Agilent Technologies Inc

ARUP Laboratories

CENTOGENE

F Hoffmann La Roche Ltd

Fulgent Genetics Inc

Invitae Corporation

Myriad Genetics Inc

BGI Group

UT Southwestern

Northwestern Medicine

Sysmex Europe SE

Premier Health

List of Tables

Table 1. Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genetic Counseling Test

Table 3. Key Players of Cancer Risk Test

Table 4. Key Players of Kits Test

Table 5. Global Gynecological Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gynecological Cancer Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gynecological Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gynecological Cancer Diagnostics Market Share by Region (2020-2025)

Table 9. Global Gynecological Cancer Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gynecological Cancer Diagnostics Market Share by Region (2026-2031)

Table 11. Gynecological Cancer Diagnostics Market Trends

Table 12. Gynecological Cancer Diagnostics Market Drivers

Table 13. Gynecological Cancer Diagnostics Market Challenges

Table 14. Gynecological Cancer Diagnostics Market Restraints

Table 15. Global Gynecological Cancer Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gynecological Cancer Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Gynecological Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2024)

Table 18. Ranking of Global Top Gynecological Cancer Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gynecological Cancer Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gynecological Cancer Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Gynecological Cancer Diagnostics, Product and Application

Table 22. Global Key Players of Gynecological Cancer Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gynecological Cancer Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Gynecological Cancer Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gynecological Cancer Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gynecological Cancer Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gynecological Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gynecological Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gynecological Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gynecological Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gynecological Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gynecological Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gynecological Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. UT Southwestern Company Details

Table 48. UT Southwestern Business Overview

Table 49. UT Southwestern Gynecological Cancer Diagnostics Product

Table 50. UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 51. UT Southwestern Recent Development

Table 52. Abramson Cancer Center Company Details

Table 53. Abramson Cancer Center Business Overview

Table 54. Abramson Cancer Center Gynecological Cancer Diagnostics Product

Table 55. Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Abramson Cancer Center Recent Development

Table 57. Northwestern Medicine Company Details

Table 58. Northwestern Medicine Business Overview

Table 59. Northwestern Medicine Gynecological Cancer Diagnostics Product

Table 60. Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 61. Northwestern Medicine Recent Development

Table 62. Sysmex Europe SE Company Details

Table 63. Sysmex Europe SE Business Overview

Table 64. Sysmex Europe SE Gynecological Cancer Diagnostics Product

Table 65. Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 66. Sysmex Europe SE Recent Development

Table 67. Fujirebio Company Details

Table 68. Fujirebio Business Overview

Table 69. Fujirebio Gynecological Cancer Diagnostics Product

Table 70. Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 71. Fujirebio Recent Development

Table 72. Premier Health Company Details

Table 73. Premier Health Business Overview

Table 74. Premier Health Gynecological Cancer Diagnostics Product

Table 75. Premier Health Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Premier Health Recent Development

Table 77. Agilent Technologies, Inc Company Details

Table 78. Agilent Technologies, Inc Business Overview

Table 79. Agilent Technologies, Inc Gynecological Cancer Diagnostics Product

Table 80. Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 81. Agilent Technologies, Inc Recent Development

Table 82. ARUP Laboratories Company Details

Table 83. ARUP Laboratories Business Overview

Table 84. ARUP Laboratories Gynecological Cancer Diagnostics Product

Table 85. ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 86. ARUP Laboratories Recent Development

Table 87. CENTOGENE Company Details

Table 88. CENTOGENE Business Overview

Table 89. CENTOGENE Gynecological Cancer Diagnostics Product

Table 90. CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 91. CENTOGENE Recent Development

Table 92. F. Hoffmann-La Roche Ltd Company Details

Table 93. F. Hoffmann-La Roche Ltd Business Overview

Table 94. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product

Table 95. F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 96. F. Hoffmann-La Roche Ltd Recent Development

Table 97. Fulgent Genetics, Inc Company Details

Table 98. Fulgent Genetics, Inc Business Overview

Table 99. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product

Table 100. Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 101. Fulgent Genetics, Inc Recent Development

Table 102. Invitae Corporation Company Details

Table 103. Invitae Corporation Business Overview

Table 104. Invitae Corporation Gynecological Cancer Diagnostics Product

Table 105. Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 106. Invitae Corporation Recent Development

Table 107. Myriad Genetics, Inc Company Details

Table 108. Myriad Genetics, Inc Business Overview

Table 109. Myriad Genetics, Inc Gynecological Cancer Diagnostics Product

Table 110. Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 111. Myriad Genetics, Inc Recent Development

Table 112. BGI Group Company Details

Table 113. BGI Group Business Overview

Table 114. BGI Group Gynecological Cancer Diagnostics Product

Table 115. BGI Group Revenue in Gynecological Cancer Diagnostics Business (2020-2025) & (US$ Million)

Table 116. BGI Group Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Gynecological Cancer Diagnostics Picture

Figure 2. Global Gynecological Cancer Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gynecological Cancer Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Genetic Counseling Test Features

Figure 5. Cancer Risk Test Features

Figure 6. Kits Test Features

Figure 7. Global Gynecological Cancer Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gynecological Cancer Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Gestational Trophoblastic Disease Diagnostics Case Studies

Figure 10. Endometrial Cancer Diagnostics Case Studies

Figure 11. Peritoneal Cancer Diagnostics Case Studies

Figure 12. Cervical Cancer Diagnostics Case Studies

Figure 13. Ovarian Cancer Diagnostics Case Studies

Figure 14. Vaginal Cancer Diagnostics Case Studies

Figure 15. Uterine Cancer Diagnostics Case Studies

Figure 16. Vulvar Cancer Diagnostics Case Studies

Figure 17. Gynecological Cancer Diagnostics Report Years Considered

Figure 18. Global Gynecological Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Gynecological Cancer Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Gynecological Cancer Diagnostics Market Share by Region: 2024 VS 2031

Figure 21. Global Gynecological Cancer Diagnostics Market Share by Players in 2024

Figure 22. Global Top Gynecological Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Gynecological Cancer Diagnostics Revenue in 2024

Figure 24. North America Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Gynecological Cancer Diagnostics Market Share by Country (2020-2031)

Figure 26. United States Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Gynecological Cancer Diagnostics Market Share by Country (2020-2031)

Figure 30. Germany Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Gynecological Cancer Diagnostics Market Share by Region (2020-2031)

Figure 38. China Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Gynecological Cancer Diagnostics Market Share by Country (2020-2031)

Figure 46. Mexico Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Gynecological Cancer Diagnostics Market Share by Country (2020-2031)

Figure 50. Turkey Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Gynecological Cancer Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. UT Southwestern Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 54. Abramson Cancer Center Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 55. Northwestern Medicine Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 56. Sysmex Europe SE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 57. Fujirebio Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 58. Premier Health Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 59. Agilent Technologies, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 60. ARUP Laboratories Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 61. CENTOGENE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 62. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 63. Fulgent Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 64. Invitae Corporation Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 65. Myriad Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 66. BGI Group Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gynecological Cancers Drug Market Research Report 2025

Global Cancer Diagnostics Service Market Research Report 2025

Global Cervical Cancer Diagnostic Testing Devices Market Research Report 2025

Global Cancer Tissue Diagnostics Market Research Report 2024

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Global Cancer Diagnostic Kit Market Research Report 2024

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Obstetrics and Gynecology Drugs Market Research Report 2025

Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precision Diagnostic Market Research Report 2024

Global Reproductive and Fertility Diagnosis Market Research Report 2025

Global Gynecological Nursing Drugs Market Research Report 2025

Next Generation Breast Cancer Diagnostic and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Personalized Medicine for Cancer Market Research Report 2025

Global Gynecological Treatment Table Market Research Report 2024

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non invasive Cancer Diagnosis Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions